0.4741USD+1.04%Mkt Cap: 19.47M $P/E: —2d ago
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The …
Industry Peers
Pharmaceutical RetailersKey Statistics
Company
Market Cap19.47M $
Enterprise Value11.19M $
Revenue (TTM)821.32K $
Gross Profit331.48K $
Net Income (TTM)-41.51M $
Revenue/Share0.0280 USD
Last Price0.4741 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4
CountryUS
SectorHealthcare
IndustryPharmaceutical Retailers
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-0.91
EV/Revenue13.62
P/S23.59
P/B0.30
EPS (TTM)-2.01
EPS (Forward)0.00
52W Range
0.238010% of range2.600
52W High2.600 USD
52W Low0.2380 USD
Profitability
Gross Margin76.80%
Oper. Margin-785.63%
EBITDA Margin0.00%
Profit Margin-9618.03%
ROE-59.20%
ROA-49.31%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.38M $
CapEx (TTM)—
FCF Margin-335.41%
FCF Yield-14.15%
Net Debt-8.19M $
Net Debt/EBITDA0.66
Balance Sheet
Debt/Equity0.00
Current Ratio3.04
Quick Ratio2.83
Book Value/Sh1.561 USD
Cash/Share0.1990 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJul 19, 2024
Pay DateJul 24, 2024
Splits
Last Split1:15
Split DateJun 22, 2023
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.500 USD
Upside (mean)+216.4%
Target Range1.500 USD – 1.500 USD
# Analysts1
Ownership
Shares Out.41.06M
Float33.14M
Insiders13.17%
Institutions5.30%
Short Interest
Short Ratio0.4d
Short % Float3.55%
Short % Out.3.30%
Shares Short1.34M
Short (prev mo.)935.99K
Technical
SMA 500.3880 (+22.2%)
SMA 2000.4527 (+4.7%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)4.24M
Avg Vol (10d)6.74M
Technical Indicators
RSI (14)69.8
MACD0.0225
MACD Signal0.0129
MACD Hist.+0.0096
BB Upper0.4794 USD
BB Middle0.4038 USD
BB Lower0.3283 USD
BB Width37.41%
ATR (14)0.0367 USD
Vol Ratio (20d)0.20x